Adagrasib,Cetuximab,Afatinib,Pembrolizumab
Mirati,Eli Lilly,Boehringer Ingelheim,Merck
['gi ', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
 christens the "chalabi plot" while presenting his own impressive data on krasi in crc. new bench marks being set for gi oncology at #esmo2022 . may we all strive for chalabi plots in our trials in the future. 
MD PhD, GI Oncologist and translational clinician scientist in gastric cancer and health technology.